Publications by authors named "Xinge Du"

Claim this Profile
I
Idiopathic Multicentric Castleman Disease With Severe Eosinophilia and Diffuse Centrilobular Nodule-A Rare Case Report.
Xiaojuan Li, Shuang Li, Tianming Zhao, Biao Xu, Xinge Du

Case Rep Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Chemokine System-Related Phenotype to Predict Immune Feature in Pan-Cancer and Prognostic Signature for Lung Adenocarcinoma.
Tianming Zhao, Xu Wu, Shiqi Guo, Jun Nie, Shitao Fang, Xinge Du

J Inflamm Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy saving and low carbon oriented renovation framework for educational buildings with Tianjin University case study.
Xinge Du, Xiang Liu, Feng Gao, Zhihua Zhou

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance Prediction and Heating Parameter Optimization of Organic-Rich Shale In Situ Conversion Based on Numerical Simulation and Artificial Intelligence Algorithms.
Yaqian Liu, Chuanjin Yao, Baishuo Liu, Yangyang Xuan, Xinge Du

ACS Omega· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental Investigation on the Pyrolysis and Conversion Characteristics of Organic-Rich Shale by Supercritical Water.
Chuanjin Yao, Fanyi Meng, Hexing Zhang, Tianyuan Di, Yiran Zhou, Xinge Du

ACS Omega· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental switch from morphological replication to compensatory growth for salamander lung regeneration.
Binxu Yin, Kun Zhang, Xinge Du, Hao Cai, Tingting Ye

Cell Prolif· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial.
Tianming Zhao, Jixiang Ni, Xuehua Hu, Yingnan Wang, Xinge Du

Clin Appl Thromb Hemost· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis